Operation Room

Essure

Bayer received FDA approval for Essure, a permanent birth control device, in 2002. During the procedure, coils are placed into a woman’s fallopian tubes. Over the next three months, a barrier forms around the inserts. This barrier, which is made of scar tissue, helps keep sperm from reaching the eggs so pregnancy cannot occur.

Over the years, the U.S. Food and Drug Administration has received over 10,000 reports of injuries ranging from pelvic pain to death since the device hit the market.

In November 2016, the U.S. Food and Drug Administration required a black box warning be added to the packaging for Essure warning of the serious complications and risk for future surgery and further restricted sales in April 2018. Bayer announced in July 2018 that Essure would no longer be sold in the United States by December 31, 2018.

If you received the Essure device and are dealing with:

  • Chronic Pain

  • Metal Allergy

  • Device Migration

  • Fallopian Tube Removal

  • Hysterectomy

  • Pregnancy

  • Ectopic Pregnancy

  • Hair Loss

  • Depression

  • Autoimmune Disorder

 

Contact D Benton Law Firm for a complimentary consultation to learn more about how to protect your rights and hold Bayer accountable for their failure to properly warn of the complications associated with a device they promoted as safe and effective.

Essure.jpg